Skip to content

Body movement of propofol in children's anesthesia induction and its causes and prevention

The study of propofol induced body movements during general anesthesia induction in children patients and its potential pre-treatment methods

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012908
Enrollment
Unknown
Registered
2017-10-09
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

propofol induced body movements during general anesthesia induction in children patients and its potential pre-treatment methods

Interventions

Mixed group and Propofol group:Propofol combined with lidocaine (propofol plus 1 ml of lidocaine per 20 ml)
Midazolam group and propofol group:Before 2 minute of anesthesia induction pretreatment of midazolam0.1mg/kg
Sufentanil group and propofol group:Pretreatment of sufentanil0.3ug/kg.min
Dexmedetomidine group and propofol group:4ug/kg.min pre-pumped dexmethomidine for 10 minute
Ketamine group 1 and propofol group:Pretreatmen of ketamine of 0.5 mg/kg
Ketamine group 2 and propofol group:Pretreatmen of ketamine of 0.6 mg/kg
Ketamine group 3 and propofol group:Pretreatmen of ketamine of 0.7 mg/kg
Ketamine group 34and propofol group:Pretreatmen of ketamine of 0.8 mg/kg

Sponsors

The Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 50 Years

Inclusion criteria

Inclusion criteria: children undergoing elective surgery under general anesthesia; ASA I-II grade; Aged 4-12 years old; cooperation with the establishment of placement of intravenous cannulation; capable of a commucation with experimenters; adults undergoing elective surgeryunder general anesthesia; ASA I-II grade; Aged 18-50 years old; surgery is expected no more than 3 h.

Exclusion criteria

Exclusion criteria: Obesity (BMI>30); with mental illness or cerebral disease;movement disorders; heart, lung, liver serious abnormal renal function; a allergy history to drug used or their composition; a history of convulsive seizures or asthma; and (1) those participate in other clinical trials of patient; (2) Other reasons are not suitable for clinical subjects according to the researchers.

Design outcomes

Primary

MeasureTime frame
The presence of pain in anesthesia induction;whether there is a body reaction;BIS values during anesthesia induction (every 5s);BIS values and time at the beginning of body movement;BIS value and time at the end of body movement;The severaty of body movement;

Secondary

MeasureTime frame
BIS value at the initial of induction;the lowest BIS values and time during induction;

Countries

China

Contacts

Public ContactSiyuan Li

The Second Affiliated Hospital of Xi'an Jiaotong University

foxlsy@163.com+86 18681875961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026